PMID: 75392Feb 18, 1978Paper

Flufenamic acid in treatment of primary spasmodic dysmenorrhoea. A double-blind crossover study

Lancet
L Kapadia, M G Elder

Abstract

A double-blind cross-over trial of flufenamic acid three times a day (200 mg) was carried out in forty-four patients with primary dysmenorrhoea. While on flufenamic for 3 months 82% of patients experienced significant pain relief. Associated gastrointestinal symptoms, i.e--vomiting and diarrhoea--were relieved in 66% and 52% patients respectively while on flufenamic acid. It is concluded that the fenamates are useful and safe drugs in the treatment of primary dysmenorrhoea.

References

Nov 30, 1957·Nature·V R PICKLES

❮ Previous
Next ❯

Citations

Dec 18, 1978·European Journal of Clinical Pharmacology·T JanbuB I Nesheim
Aug 1, 1979·Archives of Gynecology·B SandahlK E Andersson
May 19, 1986·Life Sciences·S W LevinA B Mukherjee
Nov 1, 1979·British Journal of Clinical Pharmacology·G J Sanger, A Bennett
Aug 1, 1979·British Journal of Obstetrics and Gynaecology·M G Elder, L Kapadia
Aug 18, 1979·British Medical Journal·D Davies
Aug 1, 2015·The Cochrane Database of Systematic Reviews·Jane MarjoribanksMichelle Proctor
Oct 1, 1980·British Journal of Clinical Pharmacology·A E Farah, F Rosenberg
Jan 1, 1978·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·H A SandeA Izu
Jan 1, 1980·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·G A Kintis, B Coutifaris
Jan 1, 1984·Drug Intelligence & Clinical Pharmacy·N J Wenzloff, L Shimp
Mar 15, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Athanasios Mantas, Albert Mihranyan
Jun 1, 1980·British Journal of Clinical Pharmacology·U R KrishnaU K Sheth
Jun 10, 2021·Toxicology·Mary Alexandra SchleiffGrover Paul Miller

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.